C

Cyclerion Therapeutics
D

CYCN

3.19000
USD
-0.04
(-1.09%)
مغلق
حجم التداول
1
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
9,764,411
أصول ذات صلة
ALNY
ALNY
0.47
(0.16%)
289.82 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
A
ARWR
-0.250
(-1.62%)
15.140 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
R
RCKT
-0.28500
(-4.35%)
6.26500 USD
المزيد
الأخبار المقالات

العنوان: Cyclerion Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.